AVR 0.00% $12.00 anteris technologies ltd

Ann: Successful Interim Results for the First-In-Human Trial, page-4

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,903 Posts.
    lightbulb Created with Sketch. 59
    Looks like a nice way to start a Monday:
    AVR reports thefirst-in-human DurAVR™ THV study met or exceeded its interim study objectives

    Should arrest the recent pull-back. Be interesting to see if it finds a new high?
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.